These findings supported the hypothesis that BC risk in our population was increased directly by LTL reduction, and was further affected through shortened LTL by several other variables, such as age and polymorphisms in NAT2, XRCC3, and MPO, that did not have a direct effect on BC risk. This evidence concerns the gene MPO and breast cancer.